CXCL8 and head and neck squamous cell carcinoma: The results revealed that the knockdown of IL-8 reduced NOD-mediated RIP2 activation in three types of HNSCC cell, while IL-8 siRNA treatment did not affect the expression of NOD2, according to RT-PCR (Figure 6C) and western blotting (Figure 6D).